Correlation Between DexCom and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both DexCom and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DexCom Inc and Cue Biopharma, you can compare the effects of market volatilities on DexCom and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and Cue Biopharma.
Diversification Opportunities for DexCom and Cue Biopharma
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between DexCom and Cue is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of DexCom i.e., DexCom and Cue Biopharma go up and down completely randomly.
Pair Corralation between DexCom and Cue Biopharma
Given the investment horizon of 90 days DexCom Inc is expected to generate 0.45 times more return on investment than Cue Biopharma. However, DexCom Inc is 2.21 times less risky than Cue Biopharma. It trades about -0.14 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.11 per unit of risk. If you would invest 12,495 in DexCom Inc on March 12, 2024 and sell it today you would lose (838.00) from holding DexCom Inc or give up 6.71% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
DexCom Inc vs. Cue Biopharma
Performance |
Timeline |
DexCom Inc |
Cue Biopharma |
DexCom and Cue Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with DexCom and Cue Biopharma
The main advantage of trading using opposite DexCom and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.The idea behind DexCom Inc and Cue Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Cue Biopharma vs. Krystal Biotech | Cue Biopharma vs. Apellis Pharmaceuticals | Cue Biopharma vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |